Key facts
- Notable investors include Goldport Capital, Shenzhen HTI Group, Tsing Song Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for CoreRhythm Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for CoreRhythm Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CoreRhythm Medical Technology
Developer and manufacturer of cardiac medical devices designed to provide cost-effective cardiac rhythm management solutions. The company offers cardioverter defibrillators, cardiac pacemakers, cardiac rhythm monitors and other implantable cardiac rhythm management medical devices, thereby providing heart disease patients with high-quality medical services.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2018
- Employees
- 7
- Website
- danyuan-med.com/
- Ownership
- Privately Held (backing)
CoreRhythm Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CoreRhythm Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CoreRhythm Medical Technology in its N-PORT filings yet. We sweep new filings monthly.